Normative Cognitive Decline in Old Age
Overview
Affiliations
Objective: To characterize trajectories of normative cognitive aging.
Methods: Older persons without dementia at study enrollment (n = 1,010) had annual cognitive testing for up to 24 years (mean = 9.9 years, standard deviation = 5.0), died, and underwent a neuropathologic examination to quantify 9 postmortem markers of common neurodegenerative and cerebrovascular conditions. To accommodate the heterogeneity in cognitive trajectories, we used functional mixed effects models, which allow individuals to have different patterns of cognitive decline under a unified model structure.
Results: In a functional mixed effects model, postmortem markers (Alzheimer disease pathology, Lewy bodies, transactive response DNA-binding protein 43 pathology, hippocampal sclerosis, atherosclerosis, gross infarcts) were associated with global cognitive decline. Residual global cognitive decline after adjustment for neuropathologic burden was weakly related to age at death; it occurred in only about one-third of participants, mostly proximate to death. Results were comparable after eliminating the initial cognitive assessments to minimize retest learning or controlling for frailty proximate to death. Analyses were also conducted with composite measures of episodic memory and perceptual speed. Residual decline not attributable to neuropathologic burden was confined to a subset for each outcome and was most evident proximate to death. Age at death was unrelated to residual decline in episodic memory but was related to residual decline in perceptual speed.
Interpretation: Late life cognitive loss mainly reflects non-normative pathologic and mortality-related processes rather than normative age-related processes. ANN NEUROL 2020;87:816-829.
Teng J, McKenna M, Gbadeyan O, Prakash R Netw Neurosci. 2024; 8(3):697-713.
PMID: 39355446 PMC: 11340992. DOI: 10.1162/netn_a_00373.
Rosenberg M, Beidelman E, Chen X, Kabudula C, Pettifor A, Bassil D Proc Natl Acad Sci U S A. 2024; 121(40):e2321078121.
PMID: 39298474 PMC: 11459187. DOI: 10.1073/pnas.2321078121.
Hyperhomocysteinemia and its effect on ageing and language functions - HEAL study.
Sandhya G, Monisha S, Singh S, Stezin A, Diwakar L, Issac T Sci Rep. 2024; 14(1):20101.
PMID: 39209902 PMC: 11362510. DOI: 10.1038/s41598-024-69818-1.
Cellular communities reveal trajectories of brain ageing and Alzheimer's disease.
Green G, Fujita M, Yang H, Taga M, Cain A, McCabe C Nature. 2024; 633(8030):634-645.
PMID: 39198642 PMC: 11877878. DOI: 10.1038/s41586-024-07871-6.
Clouston S, Hanes D, Smith D, Richmond L, Richards M, Link B Alzheimers Dement. 2024; 20(8):5540-5550.
PMID: 39001609 PMC: 11350020. DOI: 10.1002/alz.14053.